ArticleCancer immunology, immunotherapy : CII2019

Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.

Anthony L Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.